Recent content by Ben S

Sounds like a question for @Chad Lawton.

So, if FX-322 shows similar successful results as it did in the recent single dose study, is it likely to go to market?

I truthfully don't know how FX-322 couldn't possibly make it to market. The results speak for themselves. They've proven that it's an efficacious product, and people's lives have been changed by it. In my opinion, the reason only 33% (approx.) had a meaningful improvement is because the other...

Could FX-322 potentially aid someone like me with mild hearing loss at worst? I've noticed I've lost a little bit of sensitivity to my hearing. I unfortunately won't be able to participate in the trial as I don't posses the loss in hearing needed to be included, so I really hope this makes it...

I really hope that it repairs damaged cells, because there's no way you can have only destroyed cells and completely healthy cells with nothing in between...

It's a new month, which means we're one month closer to getting this stuff!

When I saw this slide from Otonomy's presentation regarding OTO-413 a few questions came to mind... On the first graph, it's impressive how there was a huge amount of synapses that were regenerated, but it doesn't seem to have a huge effect on practical hearing (displayed on the second graph)...

I hope that FX-322 can be approved for Expanded Access. This would be fantastic for all of us if it happens. Maybe this could be another question for Frequency Therapeutics during the the Tinnitus Talk Podcast.

Hey man, did you say that you believe your tinnitus may have been caused by alcohol ototoxicity? If so, it looks like it might be time for me to stop drinking!

Also @mrbrightside614, maybe something else you could ask is if someone like me with minor or mild hearing damage could expect a full, 100% recovery with the right amount of treatments? Perhaps the drug has a limit with its ability to regenerate.

Another question that could be asked during the interview is whether or not the newly formed hair cells and their synapses will be a strong as the ones we are born with? Or will we have to be forever cautious since they may be considerably more fragile? This is definitely a concern to me.

So I was scrolling through the thread on Dr. Mimbo Shim, and I saw that someone mentioned how Liberman and Kujawa applied for, and were approved for a synaptopathy drug patent. After looking into the patent, I saw that it was apparently abandoned today, 3/20/20? Perhaps I am misunderstanding...

Done!!! Let's hope this actually lights a fire under the asses of those who can help us!

These studies really need to allow participants to receive the real drug after getting placebo, and/or have the treatment injected into both ears. I'm sure they'd have many more participants, and therefore more data about their respective drugs.

2 years I can maybe live with, but more than that sounds pretty unbearable. I hope that the letter(s) to Dr. Woodcock may help to expedite the release FX-322. And wouldn't the synaptopathy drugs in trials be potentially eligible to receive breakthrough status too?